Toward Targeted Oral Vaccine Delivery Systems: Selection of Lectin Mimetics from Combinatorial Libraries
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Purpose Various lectins bind specifically to oligosaccharides on intestinal cells. Exploiting this specificity, Ulex europaeus agglutinin I (UEA1) has been used as a ligand for targeted oral vaccine delivery to M cells (antigen-presenting cells) in follicle-associated epithelium. In this study we characterized compounds identified from mixture-based positional scanning synthetic combinatorial libraries, which mimic UEA1 and, thus, may have properties applicable to targeted drug delivery.Methods Two UEA1 mimetics were synthesized and their activity was verified on live cells. The ability of the lead compound, a tetragalloyl D-Lysine amide construct (4-copy gallic acid construct), to deliver dye-loaded polystyrene particles to M cells was assessed in an in situ mouse gut loop model.Results The 4-copy gallic acid construct inhibited UEA1 binding to Caco-2 cell membranes with an IC50 of 3 microM, a 650- to 5000-fold increase over the natural UEA1 substrate alpha-L-fucose. The biotin-labeled derivative of this construct demonstrated comparable binding activity as verified on live cells by fluorescence-activated cell sorting. Preclinical studies confirmed its ability to mediate M cell-specific delivery of streptavidin-coated particles in vivo.Conclusions Polyphenolic compounds, D-Lysine scaffolds with multiple galloyl groups, can mimic functional activities of UEA1. Properties of such molecules, including low molecular weight, stability, ease of synthesis and low cost, highlight their potential for application in targeted vaccine delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A tetragalloyl d-lysine amide construct, as the main compound of two UEA1 mimetics, leads to successful delivery of coated PS particles to mouse M cells and might specifically bind via α-l-fucose [117].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
In the citing paper
“As data on the expression of specific receptors on human M cells is lacking, the development of M-cell-specific targeting strategies, such as the coating of particles with lectins or lectin mimetics [117,119], might be more difficult than expected.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
In the citing paper
“lectins are often toxic and susceptible to proteolytic degradation in the GI tract, which renders some of them inappropriate for in vivo application [105,117].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
Citations
Cites
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110 · cited 1×
“Protein–carbohydrate interactions are notable examples where enhanced affinity is achieved through polyvalent binding (18).”
BackgroundArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844 · cited 1×
“Caco-2 cell (ATCC, Rockville, ML, USA) membrane fractions were prepared from confluent cell monolayers grown in 75-cm(2) flasks for up to 1 week at 37°C and 5% CO2 as previously described (11,12).”
MethodPinilla, C., Appel, J. R., Blanc, P., & Houghten, R. A. (1992) · PubMed · Cited by 326
Self-citationMixture-Based Synthetic Combinatorial Libraries
Houghten, R. A., Pinilla, C., Appel, J. R., Blondelle, S. E., Dooley, C. T., Eichler, J., Nefzi, A., & Ostresh, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990174v · Cited by 256
Self-citationPurification and characterization of an anti-H(O) phytohemagglutinin of Ulex europeus
Matsumoto, I., & Osawa, T. (1969) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(69)90193-7 · Cited by 231 · cited 1×
“The 2-copy construct exhibited an IC50 value of 96 M, and the 4-copy construct 3 M, when competed against biotin-labeled UEA1 in the single-tier competition assay, representing a significant enhancement over L-fucose, which has been shown to have a range of inhibitory activity between 2000 and 15,000 M (22,24,25).”
BackgroundDifferential expression of lectin-binding sites defines mouse intestinal M-cells.
Clark, M. A., Jepson, M. A., Simmons, N. L., Booth, T. A., & Hirst, B. H. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.11.7691933 · Cited by 221 · cited 2×
“It has been established that the surface expression of oligosaccharides differs between M cells and adjacent enterocytes and that UEA1 labels the surface of mouse Peyer’s patch M cells in a highly specific manner (4,21).”
BackgroundLectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36684-4 · Cited by 172
Self-citationKinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160
Self-citationUlex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo
Foster, N. M. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00222-3 · Cited by 146 · cited 11×
“This is understandable in that early combinatorial strategies focused on peptides, primarily because of the existence of phage display libraries featuring extracellular presentation of millions of candidate ligands, and peptides were associated with biologic instability and poor membrane permeability in the GIT.”
BackgroundMethodInfluentialTargeting to intestinal M cells.
Jepson, M. A., Clark, M. A., Foster, N. M., Mason, C. M., Bennett, M. K., Simmons, N. L., & Hirst, B. H. (1996) · Europe PMC (PubMed Central) · Cited by 133
Targeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130 · cited 1×
“We and others have generated preclinical proof-of-concept data for vaccine delivery using UEA1 to enhance targeting to M cells (5,6).”
BackgroundDegenerate binding of immunogenic peptides to HLA-DR proteins on B cell Srfaces
Busch, R., Strang, G., Howland, K., & Rothbard, J. B. (1990) · International Immunology · doi:10.1093/intimm/2.5.443 · Cited by 125 · cited 1×
“This protocol was developed based on a method to detect binding of peptides to major histocompatibility molecules in whole cells (13).”
MethodCharacterization of recombinant and plant‐derived mistletoe lectin and their B‐chains
Eck, J., Langer, M., Möckel, B., Witthohn, K., Zinke, H., & Lentzen, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00784.x · Cited by 82 · cited 1×
“Already, recombinant Mistletoe Lectin 1 (ML1), produced in Escherichia coli, has exhibited similar Chinese hamster ovary cell binding properties to the native lectin (7).”
BackgroundGabor, F., Stangl, M., & Wirth, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00043-1 · Cited by 78
PARP-1: A Regulator of Genomic Stability Linked with Mammalian Longevity
Bürkle, A. (2001) · ChemBioChem · doi:10.1002/1439-7633(20011001)2:10<747::aid-cbic747>3.0.co;2-o · Cited by 75
The 2.2 Å resolution structure of the O(H) blood-group-specific lectin I from Ulex europaeus
Audette, G. F., Vandonselaar, M., & Delbaere, L. T. J. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4214 · Cited by 59 · cited 2×
“UEA1 binds the Htype 2 human blood group determinant [ -L-Fuc (1→2)- D-Gal (1→4)- -D-GlcNAc -] and recognition is coordinated by an invariant triad of residues, a common feature of legume lectins (19).”
BackgroundUse of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures
Stevenson, C. L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00331-7 · Cited by 53 · cited 2×
“Several synthetic libraries have also been screened to identify moieties, which are transported across intestinal epithelial cell monolayers (15,16).”
BackgroundMethodHořejšı́, V., & Kocourek, J. (1974) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(74)90412-7 · Cited by 45 · cited 1×
“The 2-copy construct exhibited an IC50 value of 96 M, and the 4-copy construct 3 M, when competed against biotin-labeled UEA1 in the single-tier competition assay, representing a significant enhancement over L-fucose, which has been shown to have a range of inhibitory activity between 2000 and 15,000 M (22,24,25).”
BackgroundIntestinal Absorption Screening of Mixtures from Combinatorial Libraries in the Caco-2 Model
Taylor, E. W., Gibbons, J. A., & Braeckman, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012140709158 · Cited by 44 · cited 1×
“Several synthetic libraries have also been screened to identify moieties, which are transported across intestinal epithelial cell monolayers (15,16).”
BackgroundTargeting approaches to oral drug delivery
Lambkin, I., & Pinilla, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.67 · Cited by 44
Self-citationDrug discovery and vaccine development using mixture-based synthetic combinatorial libraries
Houghten, R. A., Wilson, D. B., & Pinilla, C. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01513-0 · Cited by 38 · cited 1×
“The design and application of mixture-based synthetic combinatorial libraries has been reviewed extensively elsewhere (8,17).”
BackgroundSelf-citationMode of Molecular Recognition of l-Fucose by Fucose-Binding Legume Lectins
Thomas, C. J., & Surolia, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2110 · Cited by 10 · cited 1×
“This is expected if one considers that it is the UEA1 that binds to the L-fucose rather than L-fucose binding to the membrane preparations (23,2).”
BackgroundIdentification of novel small-Molecule Ulex europaeus I mimetics for targeted drug delivery
Hamashin, C., Spindler, L., Russell, S., Schink, A., Lambkin, I., O’Mahony, D. J., Houghten, R. A., & Pinilla, C. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.002 · Cited by 10
Self-citationEngelmann, B., Schumacher, U., & Duhm, J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90188-4 · Cited by 10 · cited 1×
“The 2-copy construct exhibited an IC50 value of 96 M, and the 4-copy construct 3 M, when competed against biotin-labeled UEA1 in the single-tier competition assay, representing a significant enhancement over L-fucose, which has been shown to have a range of inhibitory activity between 2000 and 15,000 M (22,24,25).”
BackgroundMode of Molecular Recognition of l-Fucose by Fucose-Binding Legume Lectins
Thomas, C. J., & Surolia, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2426 · Cited by 1
Research works printed but not linked: 2
- C. Pinilla, I. Lambkin, C. Hamashin, L. Osthues, L. Higgins, S. Russell, J. Dee, A. Schink, R. Houghten, and D. O'Mahony. Use of mixture-based combinatorial libraries to identify ligands that target receptors in the gastro-intestinal tract. Br. J. Pharmacol. 134:192P(2001).
- C. Grandjean, G. Angyalosi, E. Loing, A. Adriaenssens, O. Melnyk, V. Pancre, C. Auriault, and H. Gras-Masse. Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres. Chem. Biochem. 2:747-757 (2001).
Cited by
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
“Studies have also been carried out to develop/identify lectin mimetics to overcome drawbacks associated with lectins [58].”
BackgroundKeynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Xu, Y., Shrestha, N., Préat, V., & Beloqui, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.006 · Cited by 214
Delivery strategies to enhance oral vaccination against enteric infections
Davitt, C. J. H., & Lavelle, E. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.007 · Cited by 170
“Furthermore, a lowmolecular weight UEA-1 peptidomimetic has also been shown to enhance particle uptake after oral delivery [234].”
BackgroundGut-associated lymphoid tissues for the development of oral vaccines
Kunisawa, J., Kurashima, Y., & Kiyono, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.003 · Cited by 159
Metadata
- Authors
- Lambkin, I., Pinilla, C., Hamashin, C., Spindler, L., Russell, S., Schink, A., Moya-Castro, R., Allicotti, G., Higgins, L., Smith, M., Dee, J., Wilson, C., Houghten, R., & O'Mahony, D.
- Affiliations
- Trinity College Dublin (IE)
- General Atomics (United States) (US)
- Torrey Pines Institute For Molecular Studies (US)
- Corresponding author
- Lambkin, Imelda
- Venue
- Pharmaceutical Research
- Published
- 2003-08
- Volume
- 20
- Issue
- 8
- Pages
- 1258-1266
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1574479676
- Cited by
- 39
- References
- 26
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Elan
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- oral vaccine delivery, Ulex europaeus agglutinin I, M cells, follicle-associated epithelium, polyphenols, targeted drug delivery, Caco-2 cells, oligosaccharide binding
- MeSH terms
- Administration, Oral, Animals, Cell Membrane, Drug Carriers, Gallic Acid, Humans, Mice, Inbred BALB C, Microscopy, Fluorescence, Polystyrenes, Protein Binding, Structure-Activity Relationship, Vaccines, Molecular Mimicry, Caco-2 Cells, Peptide Library, Streptavidin, Combinatorial Chemistry Techniques, Plant Lectins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.